CONMED Corporation (CNMD) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.

Total Cash From Operating Activities Chart for CONMED Corporation

CONMED Corporation (CNMD) operating cash flow for FY2025 was USD 170.7M, a 2.2% change from FY2024. CONMED Corporation's operating cash flow grew from USD 5.2M in 1990 to USD 170.7M in 2025 (3182.5% over 35 years). Operating cash flow compound annual growth rate: 5-year CAGR of 21.5%, 10-year CAGR of 13.5%, 20-year CAGR of 7.2%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$1.40B
Implied Share Price
$46.72
Enterprise Value
$2.17B
Revenue (TTM)
$1.37B
EBITDA
$227.46M
Profit Margin
4.12%
Trailing P/E
25.25
Forward P/E
27.17
Price/Book (MRQ)
1.33
Price/Sales (TTM)
1.02
EV/EBITDA
11.56
EV/Revenue
1.59
Dividend Yield
—
Book Value
$34.73
Free Cash Flow (FY2025)
$150.88M
Free Cash Flow Yield
10.78%

Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.